Suppr超能文献

相似文献

1
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors.
Cancer Sci. 2010 Apr;101(4):1059-66. doi: 10.1111/j.1349-7006.2010.01491.x. Epub 2010 Jan 12.
3
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
Breast Cancer Res Treat. 2012 Apr;132(2):411-9. doi: 10.1007/s10549-011-1590-3. Epub 2011 May 24.
4
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Mol Cancer Res. 2008 Oct;6(10):1534-43. doi: 10.1158/1541-7786.MCR-07-2005.
8
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Mol Cancer Res. 2006 Jul;4(7):437-47. doi: 10.1158/1541-7786.MCR-06-0007.
10
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
J Innate Immun. 2009;1(1):59-68. doi: 10.1159/000151602. Epub 2008 Aug 28.

引用本文的文献

1
TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence.
J Innate Immun. 2025;17(1):354-368. doi: 10.1159/000545527. Epub 2025 Jun 23.
4
Understanding the Role of Toll-Like Receptors 9 in Breast Cancer.
Cancers (Basel). 2024 Jul 27;16(15):2679. doi: 10.3390/cancers16152679.
5
Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling.
Cell Biochem Biophys. 2024 Dec;82(4):3015-3030. doi: 10.1007/s12013-024-01418-2. Epub 2024 Aug 7.
6
Toll-like receptors in breast cancer immunity and immunotherapy.
Front Immunol. 2024 Jun 6;15:1418025. doi: 10.3389/fimmu.2024.1418025. eCollection 2024.
8
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
9
Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients.
Cancer Control. 2023 Jan-Dec;30:10732748231204755. doi: 10.1177/10732748231204755.
10
Identifying Key Lysosome-Related Genes Associated with Drug-Resistant Breast Cancer Using Computational and Systems Biology Approach.
Iran J Pharm Res. 2022 Oct 15;21(1):e130342. doi: 10.5812/ijpr-130342. eCollection 2022 Dec.

本文引用的文献

1
Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.
J Immunol. 2009 Sep 1;183(5):3109-17. doi: 10.4049/jimmunol.0900399. Epub 2009 Jul 31.
2
3
TLR9 signaling promotes tumor progression of human lung cancer cell in vivo.
Pathol Oncol Res. 2009 Dec;15(4):623-30. doi: 10.1007/s12253-009-9162-0. Epub 2009 Mar 25.
4
Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.
Mol Biol Cell. 2009 Apr;20(7):2041-8. doi: 10.1091/mbc.e08-07-0699. Epub 2009 Feb 11.
5
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Mol Cancer Res. 2008 Oct;6(10):1534-43. doi: 10.1158/1541-7786.MCR-07-2005.
6
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.
Clin Cancer Res. 2008 Sep 1;14(17):5626-34. doi: 10.1158/1078-0432.CCR-08-0526.
8
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
Prostate. 2007 May 15;67(7):774-81. doi: 10.1002/pros.20562.
9
FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.
Cell Death Differ. 2007 Mar;14(3):534-47. doi: 10.1038/sj.cdd.4402017. Epub 2006 Aug 4.
10
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Mol Cancer Res. 2006 Jul;4(7):437-47. doi: 10.1158/1541-7786.MCR-06-0007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验